Rubash Mark J's Form 4 filing
Intuitive Surgical Inc (ISRG) · filed Apr 24, 2023
- Accession no.
- 0001035267-23-000104
- Filed
- Apr 24, 2023
- Trade date
- Apr 21, 2023
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not checked
This filing lists 30 non-derivative transactions. Open-market sales total $2.42M. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rubash Mark JCIK 0001209186 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 21, 2023 | Common Stock | MOption exerciseAcquired | +460 | $171.07 | +$78,692.2 | 15,460 | Direct | |
| Apr 21, 2023 | Common Stock | SSaleDisposed | −460 | $297.94F2 | −$137,052.4 | 15,000 | Direct | |
| Apr 21, 2023 | Common Stock | MOption exerciseAcquired | +460 | $171.07 | +$78,692.2 | 15,460 | Direct | |
| Apr 21, 2023 | Common Stock | SSaleDisposed | −460 | $297.93F3 | −$137,047.8 | 15,000 | Direct | |
| Apr 21, 2023 | Common Stock | MOption exerciseAcquired | +460 | $171.07 | +$78,692.2 | 15,460 | Direct | |
| Apr 21, 2023 | Common Stock | SSaleDisposed | −460 | $297.94F4 | −$137,052.4 | 15,000 | Direct | |
| Apr 21, 2023 | Common Stock | MOption exerciseAcquired | +230 | $171.07 | +$39,346.1 | 15,230 | Direct | |
| Apr 21, 2023 | Common Stock | SSaleDisposed | −230 | $297.89F5 | −$68,514.7 | 15,000 | Direct | |
| Apr 21, 2023 | Common Stock | MOption exerciseAcquired | +472 | $172.59 | +$81,462.48 | 15,472 | Direct | |
| Apr 21, 2023 | Common Stock | SSaleDisposed | −472 | $297.94F2 | −$140,627.68 | 15,000 | Direct | |
| Apr 21, 2023 | Common Stock | MOption exerciseAcquired | +472 | $172.59 | +$81,462.48 | 15,472 | Direct | |
| Apr 21, 2023 | Common Stock | SSaleDisposed | −472 | $297.93F3 | −$140,622.96 | 15,000 | Direct | |
| Apr 21, 2023 | Common Stock | MOption exerciseAcquired | +472 | $172.59 | +$81,462.48 | 15,472 | Direct | |
| Apr 21, 2023 | Common Stock | SSaleDisposed | −472 | $297.94F4 | −$140,627.68 | 15,000 | Direct | |
| Apr 21, 2023 | Common Stock | MOption exerciseAcquired | +235 | $172.59 | +$40,558.65 | 15,235 | Direct | |
| Apr 21, 2023 | Common Stock | SSaleDisposed | −235 | $297.89F5 | −$70,004.15 | 15,000 | Direct | |
| Apr 21, 2023 | Common Stock | MOption exerciseAcquired | +598 | $154.24 | +$92,235.52 | 15,598 | Direct | |
| Apr 21, 2023 | Common Stock | SSaleDisposed | −598 | $297.94F2 | −$178,168.12 | 15,000 | Direct | |
| Apr 21, 2023 | Common Stock | MOption exerciseAcquired | +598 | $154.24 | +$92,235.52 | 15,598 | Direct | |
| Apr 21, 2023 | Common Stock | SSaleDisposed | −598 | $297.93F3 | −$178,162.14 | 15,000 | Direct | |
| Apr 21, 2023 | Common Stock | MOption exerciseAcquired | +598 | $154.24 | +$92,235.52 | 15,598 | Direct | |
| Apr 21, 2023 | Common Stock | SSaleDisposed | −598 | $297.94F4 | −$178,168.12 | 15,000 | Direct | |
| Apr 21, 2023 | Common Stock | MOption exerciseAcquired | +299 | $154.24 | +$46,117.76 | 15,299 | Direct | |
| Apr 21, 2023 | Common Stock | SSaleDisposed | −299 | $297.89F5 | −$89,069.11 | 15,000 | Direct | |
| Apr 21, 2023 | Common Stock | MOption exerciseAcquired | +927 | $90.49 | +$83,884.23 | 15,927 | Direct | |
| Apr 21, 2023 | Common Stock | SSaleDisposed | −927 | $297.94F2 | −$276,190.38 | 15,000 | Direct | |
| Apr 21, 2023 | Common Stock | MOption exerciseAcquired | +927 | $90.49 | +$83,884.23 | 15,927 | Direct | |
| Apr 21, 2023 | Common Stock | SSaleDisposed | −927 | $297.93F3 | −$276,181.11 | 15,000 | Direct | |
| Apr 21, 2023 | Common Stock | MOption exerciseAcquired | +927 | $90.49 | +$83,884.23 | 15,927 | Direct | |
| Apr 21, 2023 | Common Stock | SSaleDisposed | −927 | $297.94F4 | −$276,190.38 | 15,000 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $296.60 to $299.27 as follows: 638 shares sold at $296.60 to $297.49; 1,768 shares sold at $297.73 to $298.69; and 400 shares sold at $298.74 to $299.27. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
Referenced by the price of 4 transactions in Table I.
- F3
The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $296.62 to $299.27 as follows: 638 shares sold at $296.62 to $297.49; 1,718 shares sold at $297.68 to $298.67; and 450 shares sold at $298.69 to $299.27. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
Referenced by the price of 4 transactions in Table I.
- F4
The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $296.60 to $299.28 as follows: 638 shares sold at $296.60 to $297.51; 1,768 shares sold at $297.72 to $298.69; and 400 shares sold at $298.74 to $299.28. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
Referenced by the price of 4 transactions in Table I.
- F5
The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $296.45 to $299.15 as follows: 275 shares sold at $296.45 to $297.41; 888 shares sold at $297.48 to $298.48; and 237 shares sold at $298.50 to $299.15. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
Referenced by the price of 3 transactions in Table I.